Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to Soman et al.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J. Dulhunty JM, et al. Among authors: shirwadkar c. Clin Infect Dis. 2013 Jul;57(2):323-4. doi: 10.1093/cid/cit201. Epub 2013 Apr 1. Clin Infect Dis. 2013. PMID: 23547166 No abstract available.
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Udy AA, Paul SK, Lipman J; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian Society for Infectious Diseases Clinical Research Network. Dulhunty JM, et al. Among authors: shirwadkar c. Crit Care Resusc. 2013 Sep;15(3):179-85. Crit Care Resusc. 2013. PMID: 23944203 Clinical Trial.
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J; BLING II Investigators for the ANZICS Clinical Trials Group *. Dulhunty JM, et al. Among authors: shirwadkar c. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1298-305. doi: 10.1164/rccm.201505-0857OC. Am J Respir Crit Care Med. 2015. PMID: 26200166 Clinical Trial.
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
Udy AA, Dulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J; BLING-II Investigators; ANZICS Clinical Trials Group. Udy AA, et al. Among authors: shirwadkar c. Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9. Int J Antimicrob Agents. 2017. PMID: 28286115 Clinical Trial.
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Glass P, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Shirwadkar C, Starr T, Taylor C, Billot L, Dulhunty JM. Lipman J, et al. Among authors: shirwadkar c. Crit Care Resusc. 2019 Mar;21(1):63-68. Crit Care Resusc. 2019. PMID: 30857514 Clinical Trial.
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.
Finfer S, Micallef S, Hammond N, Navarra L, Bellomo R, Billot L, Delaney A, Gallagher M, Gattas D, Li Q, Mackle D, Mysore J, Saxena M, Taylor C, Young P, Myburgh J; PLUS Study Investigators and the Australian New Zealand Intensive Care Society Clinical Trials Group. Finfer S, et al. N Engl J Med. 2022 Mar 3;386(9):815-826. doi: 10.1056/NEJMoa2114464. Epub 2022 Jan 18. N Engl J Med. 2022. PMID: 35041780 Clinical Trial.
Corrigendum to "Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis" [Crit Care Resusc 23(3) (2021) 273-284].
Billot L, Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Hammond N, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Roger C, Shirwadkar C, Starr T, Taylor C, Dulhunty JM. Billot L, et al. Among authors: shirwadkar c. Crit Care Resusc. 2023 May 20;25(1):60. doi: 10.1016/j.ccrj.2023.04.012. eCollection 2023 Mar. Crit Care Resusc. 2023. PMID: 37876993 Free PMC article.
Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis.
Billot L, Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Hammond NE, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Roger C, Shirwadkar C, Starr T, Taylor C, Dulhunty JM; BLING III Investigators. Billot L, et al. Among authors: shirwadkar c. Crit Care Resusc. 2023 Oct 18;23(3):273-284. doi: 10.51893/2021.3.OA4. eCollection 2021 Sep 6. Crit Care Resusc. 2023. PMID: 38046078 Free PMC article.
Acanthamoeba encephalitis in patient with systemic lupus, India.
Shirwadkar CG, Samant R, Sankhe M, Deshpande R, Yagi S, Schuster FL, Sriram R, Visvesvara GS. Shirwadkar CG, et al. Emerg Infect Dis. 2006 Jun;12(6):984-6. doi: 10.3201/eid1206.060087. Emerg Infect Dis. 2006. PMID: 16707057 Free PMC article.
12 results